J. Trappe

发表

Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277.

D. Fabbro, K. Altmann, P. Drueckes, 2011, ACS medicinal chemistry letters.

Treatment Algorithm for Patients with Life-Threatening Ventricular Tachyarrhythmia

H. Klein, J. Trappe, 1992 .

Serum triglycerides: a comparison of a nephelometric and an enzymic method.

M. Vickers, J. Trappe, P. B. Brockington, 1975, Clinical biochemistry.

Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited

U. Hassiepen, J. Foley, J. Trappe, 2008, Diabetes, obesity & metabolism.

SGLT 2 inhibitors : a new emerging therapeutic class in the treatment of type 2 diabetes mellitus

P. Eickelmann, J. Trappe, D. Sharp, 2013 .

Surgical Techniques of Defibrillator Implantation

F. Siclari, H. Klein, J. Trappe, 1992 .

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing

Damian Szklarczyk, Doriano Fabbro, Stefan Knapp, 2011, Chemistry & biology.

Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV.

D. E. Clark, N. Ostermann, U. Hassiepen, 2014, Bioorganic & medicinal chemistry letters.

7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes

Doriano Fabbro, Stefan Knapp, Jörg Trappe, 2011, Journal of medicinal chemistry.

Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.

S. Laufer, P. Koch, U. Rothbauer, 2015, Journal of medicinal chemistry.

Mitochondrial diseases and aging.

S. Papa, P. Seibel, S. Scacco, 1996, Molecular aspects of medicine.

A high‐throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis

H. R. Bonomi, M. Carrica, F. Goldbaum, 2019, The FEBS journal.

Extended kinase profile and properties of the protein kinase inhibitor nilotinib.

J. Mestan, D. Fabbro, G. Martiny-Baron, 2010, Biochimica et biophysica acta.

Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.

P. Furet, C. Leblanc, Christine C Genick, 2017, MedChemComm.

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.

D. E. Clark, C. Higgs, N. Ostermann, 2012, Bioorganic & medicinal chemistry letters.

Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases

Gaetano Villani, Peter Seibel, Jörg Trappe, 1995, Nucleic Acids Res..

A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.

Eric Vangrevelinghe, Markus Krömer, Edgar Jacoby, 2013, Journal of medicinal chemistry.

Crystal structure of an activation intermediate of cathepsin E.

N. Ostermann, B. Gerhartz, J. Eder, 2004, Journal of molecular biology.

2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors.

Eric Vangrevelinghe, Marc Lang, Pascal Furet, 2010, Bioorganic & medicinal chemistry letters.

Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.

P. Furet, C. Leblanc, Christine C Genick, 2017, MedChemComm.